产品中心 抗体 其他一抗

所有图片(1/6)

Granzyme A Rabbit Polyclonal Antibody

CTL tryptase,Cytotoxic T-lymphocyte proteinase 1,Fragmentin-1,Granzyme-1,Hanukkah factor (H factor,HF),CTLA3,HFSP,GZMA

价格 400.00 供应商现货 : 3-5个工作日
货号 S0B1127
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    Granzyme A
  • 分子别名

    CTL tryptase, Cytotoxic T-lymphocyte proteinase 1, Fragmentin-1, Granzyme-1, Hanukkah factor (H factor; HF); CTLA3; HFSP; GZMA
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Secreted
  • Accession

    P12544
  • 抗体类型

    Polyclonal antibody
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu
  • 阳性样本

    NK-92
  • 纯化方式

    Immunogen Affinity
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    IHC-P ?

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Hu
    IHC-P 1:500 Hu
背景介绍
  • Granzyme A (GzmA) is a serine protease predominantly found in the granules of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. It plays a critical role in immune defense by inducing cell death, both apoptotic and non-apoptotic, in target cells such as virus-infected or cancerous cells. Granzyme A is known to specifically target and cleave a range of important human proteins, including histones, nuclear envelope proteins, and key DNA repair proteins like Ku70 and PARP-1. Additionally, it can activate interleukin-1, contributing to pro-inflammatory activities. Recent research has highlighted Granzyme A's ability to trigger a novel programmed cell death pathway, pyroptosis, by cleaving Gasdermin B (GSDMB), which leads to the release of its N-terminal pore-forming fragment and subsequent cell death. This mechanism is particularly relevant in the context of anti-tumor immunity, as it suggests a new way in which cytotoxic lymphocytes can eliminate target cells. The discovery of Granzyme A's role in pyroptosis has provided new insights into the mechanisms of cell death induced by the immune system and offers potential therapeutic targets for enhancing anti-tumor immunity.

  • 免疫印迹

    • WB result of Granzyme A Rabbit pAb
      Primary antibody: Granzyme A Rabbit pAb at 1/1000 dilution
      Lane 1: HeLa whole cell lysate 20 µg
      Lane 2: NK-92 whole cell lysate 20 µg
      Negative control: HeLa whole cell lysate
      Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution Predicted MW: 29 kDa
      Observed MW: 22~29 kDa

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded human spleen. Anti-Granzyme A antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human NK/T-cell lymphoma. Anti-Granzyme A antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human hepatocellular carcinoma. Anti-Granzyme A antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

  • 组织表达图谱

    • Expression of Granzyme A in tumor tissue.

    • Expression of Granzyme A in human tissue.

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)